These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 16934687
1. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687 [Abstract] [Full Text] [Related]
17. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain. Chen Z, Tang J, Liu C, Li X, Huang H, Xu X, Yu H. Nucl Med Biol; 2016 Jan 01; 43(1):124-129. PubMed ID: 26526872 [Abstract] [Full Text] [Related]
18. PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ. Nag S, Jahan M, Tóth M, Nakao R, Varrone A, Halldin C. ACS Chem Neurosci; 2021 Dec 15; 12(24):4580-4586. PubMed ID: 34813272 [Abstract] [Full Text] [Related]
19. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents. Huang Y, Bae SA, Zhu Z, Guo N, Roth BL, Laruelle M. J Med Chem; 2005 Apr 07; 48(7):2559-70. PubMed ID: 15801845 [Abstract] [Full Text] [Related]
20. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Kilbourn MR, Kuszpit K, Sherman P. Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034 [Abstract] [Full Text] [Related] Page: [Next] [New Search]